Publications

1. Bartholdy B, Christopeit M, Will B, Mo Y, Barreyro L, Yu Y, Bhagat T, Okoye-Okafor U, Todorova T, Greally J, Levine RL, Melnick A, Verma A*, Steidl U. *Co-Corresponding A human hematopoietic stem cell-commitment related DNA cytosine methylation signature is prognostic for overall survival in acute myeloid leukemia Journal of Clinical Investigation 2014 Feb 3 PMID: 24487588

2. Msaouel P, Lam AP, Gundabolu K, Chrysofakis G, Yu Y, Mantzaris I, Friedman E, Verma A. Abnormal platelet count is an independent predictor of mortality in theelderly and is influenced by ethnicity. Haematologica. 2014 Feb 7. PMID: 24510340

3. Kuo P, Leshchenko V, Fazzari M, Gellen T, Iqbal J, Baumgartner-Wennerholm S, Nygren L, Zhang F, Zhang W, Suh K, Goy A, Yang D, Chan W, Kahl B, Verma A, Gascoyne R, Kimby E, Sander B, Ye BH, Melnick A, Perumal D, He T, Parekh S High resolution Chromatin Immunoprecipitation (ChIP) sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma Oncogene, 2014 (In Press)

4. Hosono N, Makishima H, Jerez A, Yoshida K, Przychodzen B, McMahon S, Shiraishi Y, Chiba K, Tanaka H, Miyano S, Sanada M, Gómez-Seguí I, Verma AK, McDevitt MA, Sekeres MA, Ogawa S, Maciejewski JP. Recurrent genetic defects on chromosome 7q in myeloid neoplasms. Leukemia 2014 Jan 16. PMID: 24429498

5. Madzo J, Liu H, Rodriguez A, Vasanthakumar A, Sundaravel S, Caces DB, Looney TJ, Zhang L, Lepore JB, Macrae T, Duszynski R, Shih AH, Song CX, Yu M, Yu Y, Grossman R, Raumann B, Verma A, He C, Levine RL, Lavelle D, Lahn BT, Wickrema A, Godley LA. Hydroxymethylation at Gene Regulatory Regions Directs Stem/Early Progenitor Cell Commitment during Erythropoiesis Cell Reports. 2013 Dec 24 S2211-1247(13)00728-6. PMID: 24373966

6. Ko YA, Mohtat D, Suzuki M, Park AS, Izquierdo MC, Han SY, Kang HM, Si H, Hostetter T, Pullman JM, Fazzari M, Verma A, Zheng D, Greally JM, Susztak K. Cytosine methylation changes in enhancer regions of core pro-fibrotic genes characterize kidney fibrosis development. Genome Biol. 2013 Oct 7;14(10):R108. PMID: 24098934

7. Pellagatti A, Benner A, Mills K, Cazzola M, Giagounidis AAN, Perry J, Malcovati L, Giovanni M, Porta D, Jädersten M, Verma A, McDonald E, Killick S, Hellstrom-Lindberg E, Bullinger L, Wainscoat JS, Boultwood J. Identification of gene expression based prognostic markers in the hematopoietic stem cells of patients with myelodysplastic syndromes
JCO 2013 Oct 1;31(28):3557-64. PMID: 24002510

8. Lam AP, Gundabolu K, Sridharan A, Jain R, Msaouel P, Chrysofakis G, Yu Y, Friedman E, Price E, Schrier S, Verma AK Multiplicative interaction between mean corpuscular volume and red cell distribution width in predicting mortality of elderly patients with and without anemia. Am J Hematol. 2013 Nov;88(11):E245-9. PMID: 23828763

9. Yang X, Song JH, Cheng Y, Wu W, Bhagat T, Yu Y, Abraham JM, Ibrahim S, Ravich Roland W, Khashab M, Singh VK, Shin EJ, Yang X, Verma A, Meltzer SJ, Mori Y. Long Noncoding RNA HNF1A-AS1 Regulates Proliferation and Migration in Esophageal Adenocarcinoma Cells Gut 2013 Sep 2. PMID: 24000294

10. Bajpai M, Kessel R, Bhagat T, Nischal S, Yu Y, Verma A*, Das K *Co-Corresponding High resolution integrative analysis reveals widespread genetic and epigenetic changes after chronic in-vitro acid and bile exposure in Barrett's epithelium cells Genes Chromosome Cancer 2013 Oct 3. PMID: 24123713

11. Mehrotra S, Sharma B, Joshi S, Kroczynska B, Majchrzak B, Stein BL, McMahon B, Altman JK, Licht JD, Baker DP, Eklund EA, Wickrema A, Verma A, Fish EN, Platanias LC Essential role for the Mnk-pathway in the inhibitory effects of Type I interferons on myeloproliferative neoplasm (MPN) precursors JBC, 2013 (In Press)

12. Bhattacharyya, Si; Yu, Y; Suzuki, M; Campbell, N; Mazdo, J; Vasantkumar, A; Bhagat, T; Nischal, S; Christopeit, M; Parekh, S; Steidl, U; Godley, L; Maitra, A; Greally, J; Verma, A Genome wide hydroxymethylation tested using the HELP-GT assay shows redistribution in cancer Nucleic Acid Res 2013 (In Press) PMID: 23861445

13. Will B, Vogler TO, Bartholdy B, Garrett-Bakelman F, Mayer J, Barreyro L, Pandolfi A, Todorova TI, Okoye-Okafor UC, Stanley RF, Bhagat TD, Verma A, Figueroa ME, Melnick A, Roth M, Steidl U. Satb1 regulates the self-renewal of hematopoietic stem cells by promoting quiescence and repressing differentiation commitment. Nat Immunol. 2013 May;

14(5):437-45. PMID: 23563689 14. Bhagat T, Zhou L, Sokol L, Caceres G, Gundabolu K, Gordon S, Mantzaris I, Gligich O, Yu Y, Bhattacharyya S, Jing X, Polineni R, Tamari R, Bhatia K, Pellagatti A , Boultwood J, Kambhampati S, Steidl U, Stein C, Ju W, Liu G, Kenny P, List A, Bitzer M, Verma A. miR-21 mediates hematopoietic suppression in MDS by activating TGF- signaling Blood 2013, Apr 11;121(15):2875-81. PMID: 23390194

15. Yu Y, Mo Y, Liu H, Bhattacharyya S, Ebenezer D, Sundaravel S, Caces B, Ulaszek J, Artz A, Nischal S, Bhagat T, Bathon K, Maqbool S, Suzuki M, Steidl U, Godley L, Skoultchi A, Greally J, Wickrema A, Verma A High resolution methylome analysis reveals widespread hypomethylation during human erythroid differentiation JBC 2013 Mar 29;288(13):8805-14. PMID: 23306203

16. Heuck C, Mehta J, Bhagat T, Gundabolu K, Yu Y, Khan S, Chrysofakis G, Schinke C, Tariman J, Vickrey E, Pulliam N, Nischal S, Zhou L, Bhattacharya S, Meagher R, Hu C, Maqbool S, , Suzuki M, Parekh S, Reu F, Steidl U, Greally J, Verma A*, Singhal S* Co-Corresponding Myeloma is characterized by stage specific alterations in DNA methylation that occur early during myelomagenesis Journal of Immunology 2013 Mar 15;190(6):2966-75. PMID: 23408834

17. Wu W, Bhagat T, Yang X, Song J, Cheng Y, Agarwal R, Abraham J, Ibrahim S, Bartenstein M, Hussain Z, Suzuki M, Yu Y, Eng C, Greally J, Verma A*, Meltzer SJ* Co-Corresponding Hypomethylation of Noncoding DNA Regions and Overexpression of the Long Noncoding RNA, AFAP1-AS1, in Barrett’s Esophagus and Esophageal Adenocarcinoma Gastroenterology 2013 May;144(5):956-966. PMID: 23333711

18. Nischal S, Bhattacharyya S, Christopeit N, Yu Y, Zhou L, Bhagat T, Sohal S, Will B, Mo Y, Suzuki M, Pardanani A, McDevitt M, Maciejewski J, Melnick A, Greally J, Steidl U, Moliterno A, Verma A Methylome profiling reveals distinct alterations in phenotypic and mutational subgroups of myeloproliferative neoplasms Cancer Res, 2012 Dec 27. PMID: 23066032

19. Will B, Zhou L, Vogler TO, Ben-Neriah S, Schinke C,Tamari R, Yu Y, Bhagat T, Bhattacharya S, Barreyro L, Heuck C, Mo Y, Parekh S, McMahon C, Pellagatti A, Boultwood J, Montagna C, Silverman L, Maciejewski J, Greally JM, Ye BH, List AF, Steidl C, Steidl U, Verma A Stem and progenitor cells in myelodysplastic syndromes show aberrant stage specific expansion and harbor genetic and epigenetic alterations, Blood 2012; 120(10):2076-86. PMID: 22753872

20. Sokol L, Cripe L, Kantarjian H, Sekeres MA, Parmar S, Greenberg P, Goldberg SL, Bhushan V, Shammo J, Hohl R, Verma A, Garcia-Manero G, Li YP, Lowe A, Zhu J, List AF. Randomized, dose-escalation study of the p38α MAPK inhibitor SCIO-469 in patients with myelodysplastic syndrome. Leukemia. 2012 Sep 11. PMID: 23032694

21. Roth M, Will B, Simkin G, Narayanagari S, Barreyro L, Bartholdy B, Tamari R, Mitsiades CS, Verma A, Steidl U. Eltrombopag inhibits the proliferation of leukemia cells via reduction of intracellular iron and induction of differentiation. Blood. 2012 May 24. PMID: 22627766

22. Barreyro L, Will B, Bartholdy B, Zhou L, Todorova TI, Stanley RF, Ben-Neriah S, Montagna C, Parekh S, Pellagatti A, Boultwood J, Paietta E, Ketterling RP, Cripe L, Fernandez, Greenberg PL, Tallman MS, Steidl C, Mitsiades CS, Verma A, Steidl U. Overexpression of IL-1 receptor accessory protein in stem and progenitor cells and outcome correlation in AML and MDS. Blood. 2012 Aug 9;120(6):1290-8. PMID: 22723552

23. Jerez A, Sugimoto Y, Makishima H, Verma A, Jankowska AM, Przychodzen B, Visconte V, Tiu RV, O'Keefe CL, Mohamedali AM, Kulasekararaj AG, Pellagatti A, McGraw K, Muramatsu H, Moliterno AR, Sekeres MA, McDevitt MA, Kojima S, List A, Boultwood J, Mufti GJ, Maciejewski JP. Loss of heterozygosity in 7q myeloid disorders: clinical associations and genomic pathogenesis. Blood. 2012 Jun 21;119(25):6109-17. PMID: 22553315

24. Barta SK, Zou Y, Schindler J, Shenoy N, Bhagat TD, Steidl U, Verma A. Synergy of sequential administration of a deglycosylated ricin A chain-containing combined anti-CD19 and anti-CD22 immunotoxin (Combotox) and cytarabine in a murine model of advanced acute lymphoblastic leukemia. Leuk Lymphoma. 2012 Apr 18. PMID: 22448921

25. Stein BL, Williams DM, O'Keefe C, Rogers O, Ingersoll RG, Spivak JL, Verma A, Maciejewski JP, McDevitt MA, Moliterno AR. Disruption of the ASXL1 gene is frequent in primary, post-essential thrombocytosis and post-polycythemia vera myelofibrosis, but not essential thrombocytosis or polycythemia vera: analysis of molecular genetics and clinical phenotypes. Haematologica. 2011 Oct;96(10):1462-9. Epub 2011 Jun 28. PMID: 21712540

26. Sharma B, Altman JK, Goussetis DJ, Verma AK, Platanias LC. Protein kinase R as mediator of the effects of interferon (IFN) gamma and tumor necrosis factor (TNF) alpha on normal and dysplastic hematopoiesis. J Biol Chem. 2011 Aug 5;286(31):27506-14. Epub 2011 Jun 9. PMID:1659535

27. Zhou L, Opalinska J, Sohal D, Yu Y, Mo Y, Bhagat T, Abdel-Wahab O, Fazzari M, Figueroa M, Alencar C, Zhang J, Kanbhampati S, Parmar S, Nischal S, Heuck C, Suzuki M, Friedman E, Pellagatti A, Boultwood J, Steidl U, Sauthararajah Y, Yajnik V, Gore SD, Platanias LC, Levine R, Melnick A, Wickrema A, Greally JM, Verma A. Aberrant epigenetic and genetic marks are seen in myelodysplastic leucocytes and reveal DOCK4 as a candidate pathogenic gene on chr7q. J Biol Chem. 2011 Apr 30. PMID: 21532034

28. Alvarez H, Opalinska J, Zhou L, Sohal D, Fazzari M, Yu Y, Montagna C, Montgomery E, Canto M, Dunbar K, Wang J, Roa J, Mo Y, Bhagat T, Ramesh K, Cannizzaro L, Mollenhauer J, Thompson R, Suzuki M, Meltzer S, Melnick A, Greally JM, Maitra A, Verma A Widespread hypomethylation occurs early and synergizes with gene amplification during esophageal carcinogenesis. PLOS Genetics 2011 Mar;7(3) PMID: 21483804

29. L Zhou, C McMahon, T Bhagat, C Alencar, Y Yu, M Fazzari, D Sohal, C Heuck, K Gundabolu, C Ng, Y Mo, W Shen, A Wickrema, G Kong, E Friedman, L Sokol, G Mantzaris, A Pellagatti , J Boultwood, LC. Platanias. U Steidl, L Yan, JM Yingling, MM Lahn, A List, M Bitzer and A Verma Reduced SMAD7 leads to overactivation of TGF-beta signaling in MDS that can be reversed by a specific inhibitor of TGF-beta receptor I kinase. Cancer Research 2011 Feb 1;71(3):955-63.PMID: 21189329

30. Joshi S, Sharma B, Kaur S, Majchrzak B, Ueda T, Fukunaga R, Verma AK, Fish EN, Platanias LC Essential role for Mnk kinases in type II interferon (IFNgamma) signaling and its suppressive effects on normal hematopoiesis. J Biol Chem. 2011 Feb 25;286(8):6017-26.PMID: 21149447

31. Kroczynska B, Joshi S, Eklund EA, Verma A, Kotenko SV, Fish EN, Platanias LC. Regulatory effects of ribosomal S6 kinase 1 (RSK1) in IFNλ signaling. J Biol Chem. 2011 Jan 14;286(2):1147-56. Epub 2010 Nov 12.

32. Huh J, Tiu RV, Gondek LP, O'Keefe CL, Jasek M, Makishima H, Jankowska AM, Jiang Y, Verma A, Theil KS, McDevitt MA, Maciejewski JP. Characterization of chromosome arm 20q abnormalities in myeloid malignancies using genome-wide single nucleotide polymorphism array analysis. Genes Chromosomes Cancer. 2010 Apr;49(4):390-9. PMID: 20095039 33. Schinke C, Goel S, Bhagat TD, Zhou L, Mo Y, Gallagher R, Kabalka GW, Platanias LC, Verma A*, Das B Design and synthesis of novel derivatives of all-trans retinoic acid demonstrate the combined importance of acid moiety and conjugated double bonds in its binding to PML-RAR-alpha oncogene in acute promyelocytic leukemia. Leuk Lymphoma. 2010 Jun;51(6):1108-14. PMID: 20536349

34. Pellagatti A, Cazzola M, Giagounidis A, Perry J, Malcovati L, Della Porta MG, Jädersten M, Verma A, Norbury C Hellström-Lindberg E, Wainscoat JS, Boultwood J Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells. Leukemia. 2010 Apr;24(4):756-64. PMID: 20220779

35. Einstein F, Thompson RF, Bhagat TD, Fazzari MJ, Verma A, Barzilai N, Greally JM. Cytosine methylation dysregulation in neonates following intrauterine growth restriction. PLoS One. 2010 Jan 26;5(1):e8887 PMID: 20126273

36. Oda M., Glass J.L., Thompson R.F., Mo Y., Olivier E., Figueroa M.E., Selzer R.R., Richmond T.A., Zhang X., Dannenberg L., Green R., Melnick A., Hatchwell E., Bouhassira E., Verma A., Suzuki M., Greally J.M. High-resolution genome-wide cytosine methylation profiling with simultaneous copy number analysis and optimization for limited cell numbers. Nucleic Acids Res. 2009 Jul;37(12):3829-39. PMID: 19386619

37. Dumka D, Puri P, Carayol N, Lumby C, Balachandran H, Schuster K, Verma AK, Terada LS, Platanias LC, Parmar S Activation of the p38 Map kinase pathway is essential for the antileukemic effects of dasatinib. Leuk Lymphoma. 2009 Dec;50(12):2017-29. PMID: 19672773

38. Kaur S, Sassano A, Joseph AM, Majchrzak-Kita B, Eklund EA, Verma A, Brachmann SM, Fish EN, Platanias LC. Dual regulatory roles of phosphatidylinositol 3-kinase in IFN signaling. J Immunol. 2008 Nov 15;181(10):7316-23. PMID: 18981154

39. Sohal D, Yeatts A, Ye K, Pellagatti A, Zhou L, Pahanish P, Mo Y, Bhagat T, Mariadason J, Boultwood J, Melnick A, Greally JM, Verma A. Meta-analysis of microarray studies reveals a novel hematopoietic progenitor cell signature and demonstrates feasibility of inter-platform data integration. PLOS One 2008 Aug 13;3(8):e2965 PMID: 18698424

40. Zhou L, Nguyen AN, Sohal D, Ma JY, Pahanish P, Gundabolu K, Hayman J, Chubak A, Mo Y, Bhagat T, Das B, Haghnazari E, Navas T, Parmar S, Kambhampati S, Pellagati A, Braunchweig I, Zhang YE, Wickrema A, Boultwood J, Platanias LC, Higgins LS, List A, Bitzer M, Verma A. Inhibition of Transforming Growth Factor beta receptor I kinase can stimulate hematopoiesis in Myelodysplasia, Blood 2008 Oct 15;112(8):3434-43 PMID: 18474728

41. Navas T, Zhou L, Estes M, Haghnazari E, Nguyen A, Mo Y, Pahanish P, Mohindru M, Cao T, Higgins L, Platanias LC, List A, Verma A. Inhibition of p38 MAPK disrupts the pathological loop of proinflammatory factor production in the Myelodysplastic Syndrome bone marrow microenvironment. Leukemia and Lymphoma 2008 Oct;49(10):1963-75

42. Zhou L, Opalinska J, Verma A. p38 MAP kinase regulates stem cell apoptosis in human hematopoietic failure. Cell Cycle 2007, 1;6(5):534

43. Navas T, Mohindru M, Estes M, Ma JY, Sokol L, Pahanish P, Parmar S, Haghnazari E, Zhou L, Collins RC, Kerr I, Nguyen A, Xu Y, Platanias LC, List AA, Higgins LS, Verma A Inhibition of overactivated p38 MAPK can restore hematopoiesis in myelodysplastic syndrome progenitors Blood 2006, 15;108(13):4170-7

44. Verma A and List A Cytokine Targets in Myelodysplastic syndromes Current Hematology Reports 2005 Nov;4(6):429-35 45. Katsoulidis E, Li Y, Yoon P, Sassano A, Altman J, Kannan-Thulasiraman P, Balasubramanian L, Parmar S, Varga J, Tallman MS, Verma A, Platanias LC. Role of the p38 mitogen-activated protein kinase pathway in cytokine-mediated hematopoietic suppression in myelodysplastic syndromes. Cancer Res. 2005 Oct 1;65(19):9029-37.

46. Trifilio S, Ortiz R, Pennick G, Verma A, Pi J, Stosor V, Zembower T, Mehta J Voriconazole therapeutic drug monitoring in allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant. 2005 Mar;35(5):509-13.

47. Gidron A, Verma A, Doyle M, Boggio L, Evens A, Gordon L, Singhal S, Tallman M, Williams S, Winter J, Mehta J Can the stem cell mobilization technique influence CD34+ cell collection efficiency of leukapheresis procedures in patients with hematologic malignancies? Bone Marrow Transplant 2005;35(3):243-6.

48. Parmar S, Katsoulidis E, Verma A, Li Y, Sassano A, Lal L, Majchrzak B, , Ravandi F, Tallman MS, Fish EN, Platanias LC Role of the p38 mitogen-activated protein kinase pathway in the generation of the effects of imatinib mesylate (STI571) in BCR-ABL-expressing cells. J Biol Chem. 2004 Jun 11;279(24):25345-52

49. Verma A, Pedicano J, Trifilio S, Singhal S, Tallman M, Winter J, Williams S, Gordon L, Monreal J, Mehta J. How long after neutrophil recovery should myeloid growth factors be continued in autologous hematopoietic stem cell transplant recipients? Bone Marrow Transplant. 2004 Apr;33(7):715-9

50. Trifilio S, Verma A, Mehta J. Antimicrobial prophylaxis in hematopoietic stem cell transplant recipients: heterogeneity of current clinical practice. Bone Marrow Transplant. 2004 Apr;33(7):735-9

51. Verma A, Williams S, Trifilio S, Zembower T, Mehta J Successful treatment of concomitant pulmonary zygomycosis and aspergillosis with a combination of amphotericin B lipid complex, caspofungin, and voriconazole in a patient on immunosuppression for chronic graft-versus-host disease Bone Marrow Transplant. 2004 May;33(10):1065-6

52. Deonarain R, Verma A, Porter AC, Gewert DR, Platanias LC, Fish EN. Critical roles for IFN-beta in lymphoid development, myelopoiesis, and tumor development: links to tumor necrosis factor alpha. Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13453-8

53. Verma A, Devine S, Morrow M, Chen YH, Mihalov M, Peace D, Stock W, Pursell K, Wickrema A, Yassine M, Jessop E, Van Besien K. "Low incidence of CMV viremia and disease after allogeneic peripheral blood stem cell transplantation. Role of pretransplant ganciclovir and post-transplant acyclovir." Bone Marrow Transplant. 2003 May;31(9):813-6.

54. Verma A., Mohindru M., Deb D., Sassano A., Kambhampati S., Minucci S., Ravandi F., Kovakanalu D, Platanias L "Activation of the Rac1 and p38 MAP kinase pathway in response to Arsenic trioxide." Journal of Biological Chemistry 22;277(47):44988-95

55. Verma A, Sassano A, Deb D, Wickrema, A., VanBesien K., and Platanias L. "Blockade of p38 MAP kinase reverses cytokine mediated inhibition in aplastic anemia." Journal of Immunology 2002, 168 (12) (Cutting edge section)

56. Verma A, Deb D.K., Sassano A., Uddine S., Wickrema A., Varga and Platanias LC "Activation of the p38 mitogen activated protein kinase mediates suppressive effects of Type I interferons and transforming growth factor- on normal hematopoiesis." Journal of Biological Chemistry 2002, 277(10):7726-35

57. Kambhampati S, Li Y, Verma A, Sassano A, Majchrzak B, Deb DK, Parmar S, Giafis N, Kalvakolanu DV, Rahman A, Uddin , Minucci, Tallman MS, Fish EN, Platanias LC. "Activation of protein kinase C-delta (PKC-delta) by All-trans-retinoic acid." Journal of Biological Chemistry 2003 Aug 29;278(35):32544 PMID: 12805378

58. Uddin S, Sassano A, Deb D, Verma A, Majchrzak B, Rahman A, Malik A, Fish E, Platanias L "Protein Kinase delta is activated by the Type I IFN receptor and mediates phosphorylation of Stat1 on serine 727." Journal of Biological Chemistry 2002, 277(17):14408-16

59. Devine S, Hoffman R, Verma A, Shah R, Bradlow B, Stock W and Van Besien K "Allogeneic blood cell transplantation following reduced intensity conditioning is effective therapy for older patients with myelofibrosis." Blood 2002, 99(6):2255-8

60. Verma A, Stock W, Norohna S, Shah R, Bradlow B and Leonidas C. "Progressive Transformation of germinal centers: case reports and review of literature." Acta Haematologica 2002;108(1):33-8.

61. Verma A, Stock W, Lait M, Ferrer K, Quinn J, and Platanias LC "Actinomycosis presenting as a oral ulcer in a neutropenic patient." Southern Medical Journal 2002 ,95(9):1105

62. Mayer IA, Verma A, Grumbach IM, Uddin S, Fujita S, Fish EN, Platanias LC. "The p38 MAP kinase pathway mediates the growth inhibitory effects of IFN-alpha in Chronic Myelogenous Leukemia cells." The Journal of Biological Chemistry, 2001, 276(30):28570-7.

63. Sosman JA, Verma A, Moss S, Sorokin P, Blend M, Bradlow B, Chachlani N, Cutler D, Sabo R, Nelson M, Bruno E, Gustin D, Viana M, Hoffman R. "Interleukin 10-induced thrombocytopenia in normal healthy adult volunteers: evidence for decreased platelet production." British Journal of Haematology, 2000, 111(1):104-11.

64. Verma A, Kokkat A.J, and Verma, IC "The prevalence of  Thalessemia trait in school children in rural Haryana." Indian Journal of Hematology Blood Transfusion, 1996,14:86-87.

65. Verma A, Vohra A, Maitra A, Banerjee M, Singh R, Mittal SK et al. "Epidemiology of chronic suppurative otitis media and deafness in a rural area for development of an intervention strategy." Indian Journal of Pediatrics, 1995, 62(6):725-729.

66. Kokkat AJ, and Verma A "Prevalence of seizures and paralysis in a rural community." Journal of Indian Medical Assoc, 1998, 96(2):43-51.

67. Verma A, Kokkat AJ, Kalia A, Kapoor SK, Rattan A "Susceptibility of Staphylococcus aureus at a rural clinic."(letter) Natl Med J India, 1997, 10(5):255.

Review articles

1. Elias HK, Schinke C, Bhattacharyya S, Will B*, Verma A*, Steidl U* *CoCorresponding Stem cell origin of myelodysplastic syndromes Oncogene 2013 Dec 16. PMID: 24336326

2. Das BC, Thapa P, Karki R, Das S, Mahapatra S, Liu TC, Torregroza I, Wallace DP, Kambhampati S, Van Veldhuizen P, Verma A, Ray SK, Evans T. Retinoic acid signaling pathways in development and diseases. Bioorg Med Chem. 2014 Jan 15;22(2):673-83. PMID: 24393720

3. Pathak S, Roth M, Verma A*, Steidl U*. *CoCorresponding Eltrombopag for the treatment of thrombocytopenia in patients with malignant and non-malignant hematologic disorders. Expert Opin Drug Metab Toxicol. 2013 Dec;9(12):1667-75. PMID: 24215532

4. Role of DNA methylation in the pathogenesis and treatment of myelodysplastic syndromes. Khan H, Vale C, Bhagat T, Verma A. Semin Hematol. 2013 Jan;50(1):16-37. PMID: 23507481

5. Feld J, Barta SK, Schinke C, Braunschweig I, Zhou Y, Verma AK Linked-in: design and efficacy of antibody drug conjugates in oncology. Oncotarget 2013 Mar;4(3):397-412. PMID: 23651630

6. Agarwal A, Polineni R, Hussein Z, Vigoda I, Bhagat TD, Bhattacharyya S, Maitra A, Verma A. Role of epigenetic alterations in the pathogenesis of Barrett's esophagus and esophageal adenocarcinoma. Int J Clin Exp Pathol. 2012;5(5):382-96. PMID: 22808291

7. Shenoy N, Kessel R, Bhagat TD, Bhattacharyya S, Yu Y, McMahon C, Verma A. Alterations in the ribosomal machinery in cancer and hematologic disorders. J Hematol Oncol. 2012 Jun 18;5:32. PMID: 22709827

8. Elias H, Verma A Activation of hypoxia signaling is marker of poor prognosis in myelodysplasia. Leuk Lymphoma. 2012 Dec;53(12):2337-8. PMID: 22897726

9. Sharma A, Heuck C, Fazzari M, Mehta J, Singhal S, Greally JM, Verma A DNA methylation alterations seen in myeloma as a model of epigenetic changes in cancer WIREs Systems Biology and Medicine 2010 Nov-Dec;2(6):654-69. PMID: 20890963

10. Schinke C, Mo Y, Yu Y, Amiri K, Sosman J, Greally JM, Verma A Aberrant DNA methylation in malignant melanoma Melanoma Research 2010, Aug; 20(4):253-65 PMID: 20418788

11. Kotla V, Goel S, Nischal S, Heuck C, Vivek K, Das B, Verma A. Mechanism of action of lenalidomide in hematological malignancies. J Hematol Oncol. 2009 Aug 12;2:36

12. Opalinska J, Zhou L, Verma A. A new PML-RARs fusion transcript hints at the important role of PML dysregulation in the pathogenesis of APL. Leukemia Research (Commentary) 2007, 48(3):443

13. Isufi I, Seetharam M, Sohal D, Zhou L, Opalinska J, Pahanish P, Verma A. Transforming Growth Factor-beta Signaling in Normal and Malignant Hematopoiesis. Journal of Interferon and Cytokine Research 2007, 27(7):543

14. Mohindru M, Verma A Engineered antibodies act as targeted therapies in cancer treatment. Indian Journal of Pediatrics, 2005 Nov;72(11):943-7

15. Sassano A, Verma A, Platanias LC Mitogen-activated protein kinase pathways in interferon signaling. Methods Molecular Medicine, 2005;116:135-50.

16. Mohindru M, Verma A Kinase inhibitors translate lab discoveries into exciting new cures for cancers. Indian Journal of Pediatrics, 2004 Aug;71(8):713-8.

17. Verma A, Kambhampati S, Parmar S, Platanias LC. Jak family of kinases in cancer. Cancer Metastasis Rev. 2003 Dec;22(4):423-34.(rev)

18. Verma A and Platanias LC "Signaling via the interferon-a receptor in chronic myelogenous leukemia cells." Leukemia and Lymphoma 2002, 44:703-709

19. Verma A and Stock W "Management of adult lymphoblastic leukemia: moving toward a risk-adapted approach." Current Opinion in Oncology, 2001, 13:14-20.

20. Verma A and Gupta YK "The search for a super oral rehydration solution (0RS)." Drugs: News and Views, 1995, 3(2):129-132.

 
Click here to log in